Liver Cancer in China: Which Hospitals Should You Look At First?

Liver cancer is different from many other cancers because the tumor is only half the story. The liver itself may be damaged by hepatitis B, hepatitis C, alcohol-related disease, fatty liver disease, cirrhosis, portal hypertension, or previous treatments. A plan that looks good for the tumor can be unsafe if the liver reserve is poor.

So for liver cancer, the hospital question is not simply “Who removes liver tumors well?” It is also: who can judge liver function, surgical risk, interventional options, systemic therapy, recurrence risk, and follow-up?

When China may be worth considering

  • You need a second opinion on whether surgery, ablation, TACE, radiotherapy, systemic therapy, or transplant evaluation makes sense.
  • You have hepatocellular carcinoma linked to hepatitis B or cirrhosis and want a team used to managing both the tumor and the liver disease.
  • You are comparing waiting time, cost, or access for a defined procedure or multidisciplinary review.
  • Your current plan is unclear because different doctors have suggested different routes.

When not to travel first

  • You have jaundice, severe abdominal swelling, confusion, vomiting blood, serious infection, severe pain, or rapidly worsening liver function.
  • You cannot bring recent liver-function labs, coagulation results, platelet count, imaging files, and prior treatment details.
  • You are being promised surgery without a serious review of liver reserve and future liver remnant.
  • You need frequent procedures or monitoring but have no plan for follow-up after leaving China.

Departments that matter

Liver cancer may involve hepatobiliary surgery, liver tumor surgery, hepatology, infectious disease or hepatitis care, medical oncology, interventional radiology, radiation oncology, transplant evaluation, pathology, imaging, ICU, and sometimes palliative care. A hospital strong in liver surgery may still need coordination with oncology and hepatology if the patient has advanced disease or cirrhosis.

Records to prepare

  • Diagnosis summary and suspected tumor type: hepatocellular carcinoma, cholangiocarcinoma, metastasis, or unclear liver lesion.
  • Recent liver function: bilirubin, albumin, ALT/AST, INR or PT, platelet count, creatinine, sodium, and any Child-Pugh or MELD score if provided.
  • Hepatitis B, hepatitis C, viral load, antiviral therapy, cirrhosis history, ascites, variceal bleeding, or encephalopathy history.
  • AFP and other tumor markers if tested.
  • Contrast CT, MRI, ultrasound, PET-CT if done, plus DICOM image files.
  • Previous TACE, ablation, surgery, radiotherapy, targeted therapy, immunotherapy, or liver-directed treatment details.
  • Medication list, including anticoagulants, antivirals, steroids, pain medication, and supplements.

Hospitals to check first

Fudan University Zhongshan Hospital, Shanghai

Worth checking for liver cancer questions in Shanghai, especially when the decision involves liver surgery, liver function, hepatology, imaging, or multidisciplinary planning. For a foreign patient, the first step is to identify the exact liver tumor or hepatobiliary team, not just the general hospital name.

Read the hospital profile

Eastern Hepatobiliary Surgery Hospital, Shanghai

Worth checking when the main question is hepatobiliary surgery or liver-tumor procedure planning. It may be relevant for cases where surgery, ablation, or complex liver-directed treatment is being considered, but the patient’s liver reserve must be reviewed carefully.

Read the hospital profile

Sun Yat-sen University Cancer Center, Guangzhou

Worth checking for South China, especially when a cancer-center route and international-patient access matter. Ask whether the case should go through hepatobiliary surgery, medical oncology, interventional treatment, radiotherapy, or MDT.

Read the hospital profile

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Worth checking when the case needs a national cancer-center review, especially if diagnosis, staging, systemic treatment, clinical-trial review, or cross-specialty cancer planning is the main issue.

Read the hospital profile

Other names you may hear

West China Hospital, Renji Hospital, Ruijin Hospital, Peking Union Medical College Hospital, major provincial cancer hospitals, and large hepatobiliary centers may also come up. Some may be very suitable. Add them to your shortlist only after checking whether the case needs surgery, interventional treatment, systemic therapy, transplant-related review, or hepatology-first management.

Questions to ask before you choose

  • Is this definitely primary liver cancer, or could it be metastasis or cholangiocarcinoma?
  • What is my liver reserve, and does it make surgery unsafe?
  • Do I need hepatobiliary surgery, interventional radiology, oncology, hepatology, or transplant evaluation first?
  • If TACE, ablation, or radiotherapy is suggested, how many visits may be needed?
  • Who manages hepatitis B, cirrhosis, ascites, bleeding risk, or liver failure risk?
  • What is the follow-up plan after I leave China?

Use this as a shortlist, not a diagnosis. Hospitals change doctors, departments, appointment rules, international-patient services, and pricing routes. Before you travel, verify the exact department, doctor or team, documents needed, estimated timeline, cost route, and follow-up plan.

Medical disclaimer: This page is practical orientation, not medical advice, diagnosis, treatment advice, legal advice, or insurance advice.